Feb 2, 2020
Citations
0
Influential Citations
0
Citations
Journal
Definitions
Abstract
RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998 RECENT MAJOR CHANGES Contraindications (4) 03/2015 Warnings and Precautions (5.4) 04/2015 INDICATIONS AND USAGE Risedronate sodium tablets, USP are a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis (1.1) Treatment and prevention of glucocorticoid-induced osteoporosis (1.3) Treatment of Paget’s disease (1.4)